An osteoporosis guide for primary care providers to better treat their patients has been published in the journal of Family Medicine by clinicians and researchers with The University of Texas Health Science Center at Houston (UTHealth).

The early use of cold-stored platelets as an early intervention for patients with injury and hemorrhagic shock is being studied by researchers at The University of Texas Health Science Center at Houston (UTHealth) as part of a national trial.

A pilot study that hits the road to address two intersecting epidemics-– HIV among people who inject drugs and opioid dependence-– is underway at The University of Texas Health Science Center at Houston (UTHealth). 

The increased use of ridesharing apps was linked to a decrease in motor vehicle collisions and impaired driving convictions in Houston, according to published research by The University of Texas Health Science Center at Houston (UTHealth).

Changing your eating habits or altering your circadian clock can impact healthy fat tissue throughout your lifespan, according to a preclinical study published today in Nature by researchers with The University of Texas Health Science Center at Houston (UTHealth).

A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc. 

Researchers from UTHealth and Arizona State University have teamed up on the first study looking at sex-targeted drug delivery for traumatic brain injuries in a five-year, $2.5 million project funded by the National Institutes of Health. 

Infants exposed to thirdhand smoke while hospitalized in the neonatal intensive care unit (NICU) show a difference in the composition of their gut microbiome, according to a new study by researchers with The University of Texas Health Science Center at Houston (UTHealth).

There are an estimated one-million transgender adults living in the U.S. and an estimated 14% of transgender women are living with HIV. Researchers at UTHealth are studying if a combination intervention that combines HIV prevention services and hormonal therapy, supported by peer health navigation, will reduce HIV acquisition among this patient population.

Vincent Van Gogh's struggles with mental illness are often credited as the root of his artistic genius, but a UTHealth psychiatrist says that is just one thing that influenced the work of the world-renowned painter. 

New artificial intelligence technology that uses a common CT angiography (CTA) as opposed to the more advanced imaging normally required to help identify patients who could benefit from endovascular stroke therapy (EST) is being developed at UTHealth. 

Pregnant women who are hospitalized with COVID-19 and viral pneumonia are less likely than non-pregnant women to die from these infections, according to a new study by researchers with The University of Texas Health Science Center at Houston (UTHealth) and the University of Maryland School of Medicine (UMSOM).

A possible link between delirium and mortality in hospitalized older adults with acute heart failure exacerbation has been found by researchers at The University of Texas Health Science Center at Houston (UTHealth).

A fetal intervention team led by Ramesha Papanna, MD, MPH, of The University of Texas Health Science Center at Houston (UTHealth) has received a $3.2 million award from the National Institutes of Health (NIH) for preclinical research on a new approach to repair spina bifida in utero.

Black and Hispanic patients develop more disability from multiple sclerosis (MS) and respond to treatments for the disease differently compared to white patients who also have the disease, according to recent findings presented by researchers at UTHealth. 

A Phase II clinical trial to assess mesenchymal adult stem cells as a disease-modifying therapy for Parkinson's disease has been launched at The University of Texas Health Science Center at Houston (UTHealth). 

A large national clinical trial to evaluate the Pfizer-BioNTech COVID-19 vaccine for safety and efficacy in pregnant women is now open for enrollment at The University of Texas Health Science Center at Houston (UTHealth).

The John S. Dunn Foundation has made a transformative $25 million commitment to The University of Texas Health Science Center at Houston (UTHealth) to bolster the university’s behavioral health initiatives and address significant gaps in mental health care services in our communities.

The University of Texas Health Science Center at Houston (UTHealth) publicly launched its first comprehensive campaign Many Faces. One Mission. on Thursday, April 8. The campaign, representing the largest philanthropic effort in UTHealth’s history, aims to raise $500 million to address pressing health challenges and secure the institution’s future as a top health science center. Since the campaign’s quiet phase began in 2015, UTHealth’s closest friends have given more than $400 million in gifts and pledges.

A possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials has been found by researchers with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics and McGovern Medical School.

Researchers are using a novel health platform that links them to shared electronic health records from consented patients to track long-term effects of COVID-19 in a new study by UTHealth. 

Stroke patients received clot-busting medications such as tissue plasminogen activator (tPA) faster, more often, and recovered significantly better when treated via a mobile stroke unit (MSU) compared to standard management by Emergency Medical Services (EMS), according to researchers with The University of Texas Health Science Center at Houston (UTHealth) and Memorial Hermann-Texas Medical Center (TMC).

Researchers with The University of Texas Health Science Center at Houston (UTHealth) have created an acronym, RAPIDO™, to move forward much-needed efforts to address stroke sign and symptom awareness among at-risk Spanish-speaking individuals.

Treating patients with stem cells from their own bone marrow could lead to a reduction in brain injury after a stroke caused by a blood clot, according to research by The University of Texas Health Science Center at Houston (UTHealth).

Projections from Texas’ first cardiac arrest registry show that every day at least 60 Texans will suffer an out-of-hospital cardiac arrest, which is a sudden loss of heart function, breathing, and consciousness. If bystander cardiopulmonary resuscitation (CPR) is performed, the victim’s chance of survival can triple, but less than half of victims in the Lone Star State receive any bystander CPR, according to data from the registry.